Shopping Cart 0
Cart Subtotal
AED 0

Global Molecular Diagnostics Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 35819

Details

Scope of the Report:

The global Molecular Diagnostics Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Molecular Diagnostics Cancer.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Molecular Diagnostics Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Molecular Diagnostics Cancer market by product type and applications/end industries.

Market Segment by Companies, this report covers

Roche

Invitae

Abbott Laboratories

Danaher

MDxHealth

Siemens

Thermo Fisher Scientific

AstraZeneca

ICON Plc

PlexBio

Foundation Medicine

CytoTrack

Guardant Health

Luminex

10X Genomics

Merck

Biocartis

GenomOncology

Biodesix

Bio-Techne

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pharmacogenomic Diagnosis

Liquid Biopsy

Other

Market Segment by Applications, can be divided into

Respiratory Cancer

Cancer of Digestive System

Cancer of Urinary System

Cancer of Circulatory System

Motor System Cancer

Reproductive System Cancer

Other

READ MORE

Table Of Content

Scope

Table of Contents

1 Molecular Diagnostics Cancer Market Overview

1.1 Product Overview and Scope of Molecular Diagnostics Cancer

1.2 Classification of Molecular Diagnostics Cancer by Types

1.2.1 Global Molecular Diagnostics Cancer Revenue Comparison by Types (2019-2024)

1.2.2 Global Molecular Diagnostics Cancer Revenue Market Share by Types in 2018

1.2.3 Pharmacogenomic Diagnosis

1.2.4 Liquid Biopsy

1.2.5 Other

1.3 Global Molecular Diagnostics Cancer Market by Application

1.3.1 Global Molecular Diagnostics Cancer Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Respiratory Cancer

1.3.3 Cancer of Digestive System

1.3.4 Cancer of Urinary System

1.3.5 Cancer of Circulatory System

1.3.6 Motor System Cancer

1.3.7 Reproductive System Cancer

1.3.8 Other

1.4 Global Molecular Diagnostics Cancer Market by Regions

1.4.1 Global Molecular Diagnostics Cancer Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.5 Global Market Size of Molecular Diagnostics Cancer (2014-2024)

2 Company Profiles

2.1 Roche

2.1.1 Business Overview

2.1.2 Molecular Diagnostics Cancer Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Roche Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.2 Invitae

2.2.1 Business Overview

2.2.2 Molecular Diagnostics Cancer Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Invitae Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.3 Abbott Laboratories

2.3.1 Business Overview

2.3.2 Molecular Diagnostics Cancer Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Abbott Laboratories Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.4 Danaher

2.4.1 Business Overview

2.4.2 Molecular Diagnostics Cancer Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Danaher Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.5 MDxHealth

2.5.1 Business Overview

2.5.2 Molecular Diagnostics Cancer Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 MDxHealth Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.6 Siemens

2.6.1 Business Overview

2.6.2 Molecular Diagnostics Cancer Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Siemens Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.7 Thermo Fisher Scientific

2.7.1 Business Overview

2.7.2 Molecular Diagnostics Cancer Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.8 AstraZeneca

2.8.1 Business Overview

2.8.2 Molecular Diagnostics Cancer Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 AstraZeneca Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.9 ICON Plc

2.9.1 Business Overview

2.9.2 Molecular Diagnostics Cancer Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 ICON Plc Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.10 PlexBio

2.10.1 Business Overview

2.10.2 Molecular Diagnostics Cancer Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 PlexBio Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.11 Foundation Medicine

2.11.1 Business Overview

2.11.2 Molecular Diagnostics Cancer Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Foundation Medicine Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.12 CytoTrack

2.12.1 Business Overview

2.12.2 Molecular Diagnostics Cancer Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 CytoTrack Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.13 Guardant Health

2.13.1 Business Overview

2.13.2 Molecular Diagnostics Cancer Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Guardant Health Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.14 Luminex

2.14.1 Business Overview

2.14.2 Molecular Diagnostics Cancer Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Luminex Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.15 10X Genomics

2.15.1 Business Overview

2.15.2 Molecular Diagnostics Cancer Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 10X Genomics Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.16 Merck

2.16.1 Business Overview

2.16.2 Molecular Diagnostics Cancer Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Merck Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.17 Biocartis

2.17.1 Business Overview

2.17.2 Molecular Diagnostics Cancer Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Biocartis Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.18 GenomOncology

2.18.1 Business Overview

2.18.2 Molecular Diagnostics Cancer Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 GenomOncology Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.19 Biodesix

2.19.1 Business Overview

2.19.2 Molecular Diagnostics Cancer Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Biodesix Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.20 Bio-Techne

2.20.1 Business Overview

2.20.2 Molecular Diagnostics Cancer Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Bio-Techne Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

3 Global Molecular Diagnostics Cancer Market Competition, by Players

3.1 Global Molecular Diagnostics Cancer Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Molecular Diagnostics Cancer Players Market Share

3.2.2 Top 10 Molecular Diagnostics Cancer Players Market Share

3.3 Market Competition Trend

4 Global Molecular Diagnostics Cancer Market Size by Regions

4.1 Global Molecular Diagnostics Cancer Revenue and Market Share by Regions

4.2 North America Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

4.3 Europe Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

4.5 South America Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

5 North America Molecular Diagnostics Cancer Revenue by Countries

5.1 North America Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

5.2 USA Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

5.3 Canada Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

5.4 Mexico Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6 Europe Molecular Diagnostics Cancer Revenue by Countries

6.1 Europe Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

6.2 Germany Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6.3 UK Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6.4 France Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6.5 Russia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6.6 Italy Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Molecular Diagnostics Cancer Revenue by Countries

7.1 Asia-Pacific Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

7.2 China Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7.3 Japan Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7.4 Korea Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7.5 India Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

8 South America Molecular Diagnostics Cancer Revenue by Countries

8.1 South America Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

8.2 Brazil Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

8.3 Argentina Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

8.4 Colombia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Molecular Diagnostics Cancer by Countries

9.1 Middle East and Africa Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

9.2 Saudi Arabia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9.3 UAE Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9.4 Egypt Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9.5 Nigeria Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9.6 South Africa Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

10 Global Molecular Diagnostics Cancer Market Segment by Type

10.1 Global Molecular Diagnostics Cancer Revenue and Market Share by Type (2014-2019)

10.2 Global Molecular Diagnostics Cancer Market Forecast by Type (2019-2024)

10.3 Pharmacogenomic Diagnosis Revenue Growth Rate (2014-2024)

10.4 Liquid Biopsy Revenue Growth Rate (2014-2024)

10.5 Other Revenue Growth Rate (2014-2024)

11 Global Molecular Diagnostics Cancer Market Segment by Application

11.1 Global Molecular Diagnostics Cancer Revenue Market Share by Application (2014-2019)

11.2 Molecular Diagnostics Cancer Market Forecast by Application (2019-2024)

11.3 Respiratory Cancer Revenue Growth (2014-2019)

11.4 Cancer of Digestive System Revenue Growth (2014-2019)

11.5 Cancer of Urinary System Revenue Growth (2014-2019)

11.6 Cancer of Circulatory System Revenue Growth (2014-2019)

11.7 Motor System Cancer Revenue Growth (2014-2019)

11.8 Reproductive System Cancer Revenue Growth (2014-2019)

11.9 Other Revenue Growth (2014-2019)

12 Global Molecular Diagnostics Cancer Market Size Forecast (2019-2024)

12.1 Global Molecular Diagnostics Cancer Market Size Forecast (2019-2024)

12.2 Global Molecular Diagnostics Cancer Market Forecast by Regions (2019-2024)

12.3 North America Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

12.4 Europe Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

12.6 South America Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Figure

List of Tables and Figures

Figure Molecular Diagnostics Cancer Picture

Table Product Specifications of Molecular Diagnostics Cancer

Table Global Molecular Diagnostics Cancer and Revenue (Million USD) Market Split by Product Type

Figure Global Molecular Diagnostics Cancer Revenue Market Share by Types in 2018

Figure Pharmacogenomic Diagnosis Picture

Figure Liquid Biopsy Picture

Figure Other Picture

Table Global Molecular Diagnostics Cancer Revenue (Million USD) by Application (2014-2024)

Figure Molecular Diagnostics Cancer Revenue Market Share by Applications in 2018

Figure Respiratory Cancer Picture

Figure Cancer of Digestive System Picture

Figure Cancer of Urinary System Picture

Figure Cancer of Circulatory System Picture

Figure Motor System Cancer Picture

Figure Reproductive System Cancer Picture

Figure Other Picture

Table Global Market Molecular Diagnostics Cancer Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Molecular Diagnostics Cancer Type and Applications

Table Roche Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Invitae Basic Information, Manufacturing Base and Competitors

Table Invitae Molecular Diagnostics Cancer Type and Applications

Table Invitae Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Molecular Diagnostics Cancer Type and Applications

Table Abbott Laboratories Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Danaher Basic Information, Manufacturing Base and Competitors

Table Danaher Molecular Diagnostics Cancer Type and Applications

Table Danaher Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table MDxHealth Basic Information, Manufacturing Base and Competitors

Table MDxHealth Molecular Diagnostics Cancer Type and Applications

Table MDxHealth Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Siemens Basic Information, Manufacturing Base and Competitors

Table Siemens Molecular Diagnostics Cancer Type and Applications

Table Siemens Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors

Table Thermo Fisher Scientific Molecular Diagnostics Cancer Type and Applications

Table Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Molecular Diagnostics Cancer Type and Applications

Table AstraZeneca Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table ICON Plc Basic Information, Manufacturing Base and Competitors

Table ICON Plc Molecular Diagnostics Cancer Type and Applications

Table ICON Plc Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table PlexBio Basic Information, Manufacturing Base and Competitors

Table PlexBio Molecular Diagnostics Cancer Type and Applications

Table PlexBio Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Foundation Medicine Basic Information, Manufacturing Base and Competitors

Table Foundation Medicine Molecular Diagnostics Cancer Type and Applications

Table Foundation Medicine Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table CytoTrack Basic Information, Manufacturing Base and Competitors

Table CytoTrack Molecular Diagnostics Cancer Type and Applications

Table CytoTrack Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Guardant Health Basic Information, Manufacturing Base and Competitors

Table Guardant Health Molecular Diagnostics Cancer Type and Applications

Table Guardant Health Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Luminex Basic Information, Manufacturing Base and Competitors

Table Luminex Molecular Diagnostics Cancer Type and Applications

Table Luminex Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table 10X Genomics Basic Information, Manufacturing Base and Competitors

Table 10X Genomics Molecular Diagnostics Cancer Type and Applications

Table 10X Genomics Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Molecular Diagnostics Cancer Type and Applications

Table Merck Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Biocartis Basic Information, Manufacturing Base and Competitors

Table Biocartis Molecular Diagnostics Cancer Type and Applications

Table Biocartis Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table GenomOncology Basic Information, Manufacturing Base and Competitors

Table GenomOncology Molecular Diagnostics Cancer Type and Applications

Table GenomOncology Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Biodesix Basic Information, Manufacturing Base and Competitors

Table Biodesix Molecular Diagnostics Cancer Type and Applications

Table Biodesix Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Bio-Techne Basic Information, Manufacturing Base and Competitors

Table Bio-Techne Molecular Diagnostics Cancer Type and Applications

Table Bio-Techne Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Global Molecular Diagnostics Cancer Revenue (Million USD) by Players (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue Share by Players (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Players in 2017

Figure Global Molecular Diagnostics Cancer Revenue Share by Players in 2018

Figure Global Top 5 Players Molecular Diagnostics Cancer Revenue Market Share in 2018

Figure Global Top 10 Players Molecular Diagnostics Cancer Revenue Market Share in 2018

Figure Global Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue (Million USD) by Regions (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue Market Share by Regions (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Market Share by Regions (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Market Share by Regions in 2018

Figure North America Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Europe Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure South America Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table North America Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

Table North America Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure North America Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure North America Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure USA Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Canada Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Mexico Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table Europe Molecular Diagnostics Cancer Revenue (Million USD) by Countries (2014-2019)

Figure Europe Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure Europe Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure Germany Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure UK Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure France Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Russia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Italy Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Molecular Diagnostics Cancer Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure China Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Japan Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Korea Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure India Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table South America Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

Table South America Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure South America Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure South America Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure Brazil Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Argentina Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Colombia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Molecular Diagnostics Cancer Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure Saudi Arabia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure UAE Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Egypt Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Nigeria Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure South Africa Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue (Million USD) by Type (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue Share by Type (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Type (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Type in 2018

Table Global Molecular Diagnostics Cancer Revenue Forecast by Type (2019-2024)

Figure Global Molecular Diagnostics Cancer Market Share Forecast by Type (2019-2024)

Figure Global Pharmacogenomic Diagnosis Revenue Growth Rate (2014-2019)

Figure Global Liquid Biopsy Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue by Application (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue Share by Application (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Application (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Application in 2018

Table Global Molecular Diagnostics Cancer Revenue Forecast by Application (2019-2024)

Figure Global Molecular Diagnostics Cancer Market Share Forecast by Application (2019-2024)

Figure Global Respiratory Cancer Revenue Growth Rate (2014-2019)

Figure Global Cancer of Digestive System Revenue Growth Rate (2014-2019)

Figure Global Cancer of Urinary System Revenue Growth Rate (2014-2019)

Figure Global Cancer of Circulatory System Revenue Growth Rate (2014-2019)

Figure Global Motor System Cancer Revenue Growth Rate (2014-2019)

Figure Global Reproductive System Cancer Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Molecular Diagnostics Cancer Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Molecular Diagnostics Cancer Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Figure Europe Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Figure South America Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Roche

Invitae

Abbott Laboratories

Danaher

MDxHealth

Siemens

Thermo Fisher Scientific

AstraZeneca

ICON Plc

PlexBio

Foundation Medicine

CytoTrack

Guardant Health

Luminex

10X Genomics

Merck

Biocartis

GenomOncology

Biodesix

Bio-Techne

Company Profile

Company Profile Title

Scope of the Report:

The global Molecular Diagnostics Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Molecular Diagnostics Cancer.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Molecular Diagnostics Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Molecular Diagnostics Cancer market by product type and applications/end industries.

Market Segment by Companies, this report covers

Roche

Invitae

Abbott Laboratories

Danaher

MDxHealth

Siemens

Thermo Fisher Scientific

AstraZeneca

ICON Plc

PlexBio

Foundation Medicine

CytoTrack

Guardant Health

Luminex

10X Genomics

Merck

Biocartis

GenomOncology

Biodesix

Bio-Techne

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pharmacogenomic Diagnosis

Liquid Biopsy

Other

Market Segment by Applications, can be divided into

Respiratory Cancer

Cancer of Digestive System

Cancer of Urinary System

Cancer of Circulatory System

Motor System Cancer

Reproductive System Cancer

Other

READ MORE

Scope

Table of Contents

1 Molecular Diagnostics Cancer Market Overview

1.1 Product Overview and Scope of Molecular Diagnostics Cancer

1.2 Classification of Molecular Diagnostics Cancer by Types

1.2.1 Global Molecular Diagnostics Cancer Revenue Comparison by Types (2019-2024)

1.2.2 Global Molecular Diagnostics Cancer Revenue Market Share by Types in 2018

1.2.3 Pharmacogenomic Diagnosis

1.2.4 Liquid Biopsy

1.2.5 Other

1.3 Global Molecular Diagnostics Cancer Market by Application

1.3.1 Global Molecular Diagnostics Cancer Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Respiratory Cancer

1.3.3 Cancer of Digestive System

1.3.4 Cancer of Urinary System

1.3.5 Cancer of Circulatory System

1.3.6 Motor System Cancer

1.3.7 Reproductive System Cancer

1.3.8 Other

1.4 Global Molecular Diagnostics Cancer Market by Regions

1.4.1 Global Molecular Diagnostics Cancer Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Diagnostics Cancer Status and Prospect (2014-2024)

1.5 Global Market Size of Molecular Diagnostics Cancer (2014-2024)

2 Company Profiles

2.1 Roche

2.1.1 Business Overview

2.1.2 Molecular Diagnostics Cancer Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Roche Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.2 Invitae

2.2.1 Business Overview

2.2.2 Molecular Diagnostics Cancer Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Invitae Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.3 Abbott Laboratories

2.3.1 Business Overview

2.3.2 Molecular Diagnostics Cancer Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Abbott Laboratories Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.4 Danaher

2.4.1 Business Overview

2.4.2 Molecular Diagnostics Cancer Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Danaher Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.5 MDxHealth

2.5.1 Business Overview

2.5.2 Molecular Diagnostics Cancer Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 MDxHealth Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.6 Siemens

2.6.1 Business Overview

2.6.2 Molecular Diagnostics Cancer Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Siemens Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.7 Thermo Fisher Scientific

2.7.1 Business Overview

2.7.2 Molecular Diagnostics Cancer Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.8 AstraZeneca

2.8.1 Business Overview

2.8.2 Molecular Diagnostics Cancer Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 AstraZeneca Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.9 ICON Plc

2.9.1 Business Overview

2.9.2 Molecular Diagnostics Cancer Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 ICON Plc Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.10 PlexBio

2.10.1 Business Overview

2.10.2 Molecular Diagnostics Cancer Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 PlexBio Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.11 Foundation Medicine

2.11.1 Business Overview

2.11.2 Molecular Diagnostics Cancer Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Foundation Medicine Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.12 CytoTrack

2.12.1 Business Overview

2.12.2 Molecular Diagnostics Cancer Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 CytoTrack Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.13 Guardant Health

2.13.1 Business Overview

2.13.2 Molecular Diagnostics Cancer Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Guardant Health Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.14 Luminex

2.14.1 Business Overview

2.14.2 Molecular Diagnostics Cancer Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Luminex Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.15 10X Genomics

2.15.1 Business Overview

2.15.2 Molecular Diagnostics Cancer Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 10X Genomics Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.16 Merck

2.16.1 Business Overview

2.16.2 Molecular Diagnostics Cancer Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Merck Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.17 Biocartis

2.17.1 Business Overview

2.17.2 Molecular Diagnostics Cancer Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Biocartis Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.18 GenomOncology

2.18.1 Business Overview

2.18.2 Molecular Diagnostics Cancer Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 GenomOncology Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.19 Biodesix

2.19.1 Business Overview

2.19.2 Molecular Diagnostics Cancer Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Biodesix Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

2.20 Bio-Techne

2.20.1 Business Overview

2.20.2 Molecular Diagnostics Cancer Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Bio-Techne Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

3 Global Molecular Diagnostics Cancer Market Competition, by Players

3.1 Global Molecular Diagnostics Cancer Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Molecular Diagnostics Cancer Players Market Share

3.2.2 Top 10 Molecular Diagnostics Cancer Players Market Share

3.3 Market Competition Trend

4 Global Molecular Diagnostics Cancer Market Size by Regions

4.1 Global Molecular Diagnostics Cancer Revenue and Market Share by Regions

4.2 North America Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

4.3 Europe Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

4.5 South America Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

5 North America Molecular Diagnostics Cancer Revenue by Countries

5.1 North America Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

5.2 USA Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

5.3 Canada Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

5.4 Mexico Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6 Europe Molecular Diagnostics Cancer Revenue by Countries

6.1 Europe Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

6.2 Germany Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6.3 UK Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6.4 France Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6.5 Russia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

6.6 Italy Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Molecular Diagnostics Cancer Revenue by Countries

7.1 Asia-Pacific Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

7.2 China Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7.3 Japan Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7.4 Korea Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7.5 India Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

8 South America Molecular Diagnostics Cancer Revenue by Countries

8.1 South America Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

8.2 Brazil Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

8.3 Argentina Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

8.4 Colombia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Molecular Diagnostics Cancer by Countries

9.1 Middle East and Africa Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

9.2 Saudi Arabia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9.3 UAE Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9.4 Egypt Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9.5 Nigeria Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

9.6 South Africa Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

10 Global Molecular Diagnostics Cancer Market Segment by Type

10.1 Global Molecular Diagnostics Cancer Revenue and Market Share by Type (2014-2019)

10.2 Global Molecular Diagnostics Cancer Market Forecast by Type (2019-2024)

10.3 Pharmacogenomic Diagnosis Revenue Growth Rate (2014-2024)

10.4 Liquid Biopsy Revenue Growth Rate (2014-2024)

10.5 Other Revenue Growth Rate (2014-2024)

11 Global Molecular Diagnostics Cancer Market Segment by Application

11.1 Global Molecular Diagnostics Cancer Revenue Market Share by Application (2014-2019)

11.2 Molecular Diagnostics Cancer Market Forecast by Application (2019-2024)

11.3 Respiratory Cancer Revenue Growth (2014-2019)

11.4 Cancer of Digestive System Revenue Growth (2014-2019)

11.5 Cancer of Urinary System Revenue Growth (2014-2019)

11.6 Cancer of Circulatory System Revenue Growth (2014-2019)

11.7 Motor System Cancer Revenue Growth (2014-2019)

11.8 Reproductive System Cancer Revenue Growth (2014-2019)

11.9 Other Revenue Growth (2014-2019)

12 Global Molecular Diagnostics Cancer Market Size Forecast (2019-2024)

12.1 Global Molecular Diagnostics Cancer Market Size Forecast (2019-2024)

12.2 Global Molecular Diagnostics Cancer Market Forecast by Regions (2019-2024)

12.3 North America Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

12.4 Europe Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

12.6 South America Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Figure

List of Tables and Figures

Figure Molecular Diagnostics Cancer Picture

Table Product Specifications of Molecular Diagnostics Cancer

Table Global Molecular Diagnostics Cancer and Revenue (Million USD) Market Split by Product Type

Figure Global Molecular Diagnostics Cancer Revenue Market Share by Types in 2018

Figure Pharmacogenomic Diagnosis Picture

Figure Liquid Biopsy Picture

Figure Other Picture

Table Global Molecular Diagnostics Cancer Revenue (Million USD) by Application (2014-2024)

Figure Molecular Diagnostics Cancer Revenue Market Share by Applications in 2018

Figure Respiratory Cancer Picture

Figure Cancer of Digestive System Picture

Figure Cancer of Urinary System Picture

Figure Cancer of Circulatory System Picture

Figure Motor System Cancer Picture

Figure Reproductive System Cancer Picture

Figure Other Picture

Table Global Market Molecular Diagnostics Cancer Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (2014-2024)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Molecular Diagnostics Cancer Type and Applications

Table Roche Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Invitae Basic Information, Manufacturing Base and Competitors

Table Invitae Molecular Diagnostics Cancer Type and Applications

Table Invitae Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Molecular Diagnostics Cancer Type and Applications

Table Abbott Laboratories Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Danaher Basic Information, Manufacturing Base and Competitors

Table Danaher Molecular Diagnostics Cancer Type and Applications

Table Danaher Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table MDxHealth Basic Information, Manufacturing Base and Competitors

Table MDxHealth Molecular Diagnostics Cancer Type and Applications

Table MDxHealth Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Siemens Basic Information, Manufacturing Base and Competitors

Table Siemens Molecular Diagnostics Cancer Type and Applications

Table Siemens Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors

Table Thermo Fisher Scientific Molecular Diagnostics Cancer Type and Applications

Table Thermo Fisher Scientific Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Molecular Diagnostics Cancer Type and Applications

Table AstraZeneca Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table ICON Plc Basic Information, Manufacturing Base and Competitors

Table ICON Plc Molecular Diagnostics Cancer Type and Applications

Table ICON Plc Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table PlexBio Basic Information, Manufacturing Base and Competitors

Table PlexBio Molecular Diagnostics Cancer Type and Applications

Table PlexBio Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Foundation Medicine Basic Information, Manufacturing Base and Competitors

Table Foundation Medicine Molecular Diagnostics Cancer Type and Applications

Table Foundation Medicine Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table CytoTrack Basic Information, Manufacturing Base and Competitors

Table CytoTrack Molecular Diagnostics Cancer Type and Applications

Table CytoTrack Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Guardant Health Basic Information, Manufacturing Base and Competitors

Table Guardant Health Molecular Diagnostics Cancer Type and Applications

Table Guardant Health Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Luminex Basic Information, Manufacturing Base and Competitors

Table Luminex Molecular Diagnostics Cancer Type and Applications

Table Luminex Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table 10X Genomics Basic Information, Manufacturing Base and Competitors

Table 10X Genomics Molecular Diagnostics Cancer Type and Applications

Table 10X Genomics Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Molecular Diagnostics Cancer Type and Applications

Table Merck Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Biocartis Basic Information, Manufacturing Base and Competitors

Table Biocartis Molecular Diagnostics Cancer Type and Applications

Table Biocartis Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table GenomOncology Basic Information, Manufacturing Base and Competitors

Table GenomOncology Molecular Diagnostics Cancer Type and Applications

Table GenomOncology Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Biodesix Basic Information, Manufacturing Base and Competitors

Table Biodesix Molecular Diagnostics Cancer Type and Applications

Table Biodesix Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Bio-Techne Basic Information, Manufacturing Base and Competitors

Table Bio-Techne Molecular Diagnostics Cancer Type and Applications

Table Bio-Techne Molecular Diagnostics Cancer Revenue, Gross Margin and Market Share (2017-2018)

Table Global Molecular Diagnostics Cancer Revenue (Million USD) by Players (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue Share by Players (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Players in 2017

Figure Global Molecular Diagnostics Cancer Revenue Share by Players in 2018

Figure Global Top 5 Players Molecular Diagnostics Cancer Revenue Market Share in 2018

Figure Global Top 10 Players Molecular Diagnostics Cancer Revenue Market Share in 2018

Figure Global Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue (Million USD) by Regions (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue Market Share by Regions (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Market Share by Regions (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Market Share by Regions in 2018

Figure North America Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Europe Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure South America Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table North America Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

Table North America Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure North America Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure North America Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure USA Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Canada Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Mexico Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table Europe Molecular Diagnostics Cancer Revenue (Million USD) by Countries (2014-2019)

Figure Europe Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure Europe Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure Germany Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure UK Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure France Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Russia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Italy Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Molecular Diagnostics Cancer Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure China Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Japan Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Korea Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure India Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table South America Molecular Diagnostics Cancer Revenue by Countries (2014-2019)

Table South America Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure South America Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure South America Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure Brazil Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Argentina Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Colombia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Molecular Diagnostics Cancer Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue Market Share by Countries in 2018

Figure Saudi Arabia Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure UAE Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Egypt Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure Nigeria Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Figure South Africa Molecular Diagnostics Cancer Revenue and Growth Rate (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue (Million USD) by Type (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue Share by Type (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Type (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Type in 2018

Table Global Molecular Diagnostics Cancer Revenue Forecast by Type (2019-2024)

Figure Global Molecular Diagnostics Cancer Market Share Forecast by Type (2019-2024)

Figure Global Pharmacogenomic Diagnosis Revenue Growth Rate (2014-2019)

Figure Global Liquid Biopsy Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue by Application (2014-2019)

Table Global Molecular Diagnostics Cancer Revenue Share by Application (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Application (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue Share by Application in 2018

Table Global Molecular Diagnostics Cancer Revenue Forecast by Application (2019-2024)

Figure Global Molecular Diagnostics Cancer Market Share Forecast by Application (2019-2024)

Figure Global Respiratory Cancer Revenue Growth Rate (2014-2019)

Figure Global Cancer of Digestive System Revenue Growth Rate (2014-2019)

Figure Global Cancer of Urinary System Revenue Growth Rate (2014-2019)

Figure Global Cancer of Circulatory System Revenue Growth Rate (2014-2019)

Figure Global Motor System Cancer Revenue Growth Rate (2014-2019)

Figure Global Reproductive System Cancer Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Figure Global Molecular Diagnostics Cancer Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Molecular Diagnostics Cancer Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Molecular Diagnostics Cancer Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Figure Europe Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Figure South America Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Molecular Diagnostics Cancer Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Roche

Invitae

Abbott Laboratories

Danaher

MDxHealth

Siemens

Thermo Fisher Scientific

AstraZeneca

ICON Plc

PlexBio

Foundation Medicine

CytoTrack

Guardant Health

Luminex

10X Genomics

Merck

Biocartis

GenomOncology

Biodesix

Bio-Techne